Mycobacterial Diseases at IPHC 2027

Mycobacterial diseases are a group of infectious illnesses caused by bacteria belonging to the genus Mycobacterium. Notable among these diseases is tuberculosis (TB), caused by Mycobacterium tuberculosis, and leprosy, caused by Mycobacterium leprae. Tuberculosis primarily affects the lungs and can be transmitted through the air when an infected person coughs or sneezes. It remains a significant global health concern, with symptoms ranging from persistent cough and weight loss to fatigue and fever. Treatment involves a course of antibiotics, and efforts are ongoing to enhance diagnostics and access to care. Leprosy, on the other hand, primarily affects the skin and peripheral nerves. While less common today, pockets of the disease persist in some regions. Early diagnosis and treatment with multidrug therapy are crucial to prevent complications and disabilities associated with leprosy. Both TB and leprosy are communicable diseases, and their control involves strategies such as timely diagnosis, effective treatment, and public health measures to prevent the spread of the bacteria. Vaccines, like the Bacillus Calmette-Guérin (BCG) vaccine for TB, are used to reduce the incidence of these diseases, especially in regions where they are endemic. Mycobacterial diseases highlight the importance of comprehensive public health efforts, including education, vaccination, and accessible healthcare, in managing and preventing the transmission of these communicable diseases. Ongoing research and advancements in diagnostics and treatment continue to contribute to the global efforts to control and eliminate mycobacterial diseases.